Probert J C, Lederman M, Bagshaw M A
Calif Med. 1973 Jan;118(1):14-7.
In a series of 17 biopsy-proved cases of medulloblastoma all patients were treated by megavoltage irradiation in the Stanford University Division of Radiation Therapy. The entire craniospinal axis was treated in each case. The five-year survival in the series was 27 percent. Two ten-year survivors were studied in detail. The major longterm disability was inhibition of growth of the vertebral column. In this series, a normal tissue nominal standard dose of at least 1275 rets was necessary for tumor control.
在一系列17例经活检证实的髓母细胞瘤病例中,所有患者均在斯坦福大学放射治疗科接受了兆伏级放疗。每例患者均对整个颅脊柱轴进行了治疗。该系列病例的五年生存率为27%。对两名十年存活者进行了详细研究。主要的长期残疾是脊柱生长受抑制。在该系列中,肿瘤控制需要至少1275rets的正常组织标称标准剂量。